Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

Leukemia and Lymphoma

Volumn 46, Issue 9, 2005, Pages 1313-1320

  Vogl, Dan T ^a   Glatstein, Eli ^a   Carver, Joseph R ^a   Schuster, Stephen J ^a   Stadtmauer, Edward A ^a   Luger, Selina ^a   Nasta, Sunita D ^a   Porter, David L ^a   Elstrom, Rebecca ^a   Tsai, Donald E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiac tamponade; Gemcitabine; Mediastinum; Pericardial effusion; Radiation recall; Radiotherapy

Indexed keywords

ALEMTUZUMAB; BEXAROTENE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DENILEUKIN DIFTITOX; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; IFOSFAMIDE; INTERFERON; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; THALIDOMIDE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HEART TAMPONADE; HEMODYNAMICS; HUMAN; IRRADIATION; LUNG TOXICITY; LYMPHOMA; MALE; MEDIASTINUM; PERICARDIAL EFFUSION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RADIATION SICKNESS; SURGICAL TECHNIQUE;

ADULT; CARDIAC TAMPONADE; DEOXYCYTIDINE; FEMALE; HEART; HUMANS; LYMPHOMA; MALE; MEDIASTINUM; MIDDLE AGED; PERICARDIAL EFFUSION; RADIATION INJURIES;

EID: 24644523667     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500158649     Document Type: Article

References (19)

1. Castellano D, Hitt R, Cortes-Funes H, Romero A, Rodriguez-Peralto JL. Radiation recall reaction induced by gemcitabine. Journal of Clinical Oncology 2000;18:695-696.
2. Schwartz BM, Khuntia D, Kennedy AW, Markman M. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecologic Oncology 2003;91:421-422.
3. Burstein HJ. Radiation recall dermatitis from gemcitabine. Journal of Clinical Oncology 2000;18:693-694.
4. Bar-Sela G, Beny A, Bergman R, Kuten A. Gemcitabine-induced radiation recall dermatitis: a case report. Tumori 2001;87:428-430.
5. Fogarty G, Ball D, Rischin D. Radiation recall reaction following gemcitabine. Lung Cancer 2001;33:299-302.
6. Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuch CS, Loeffler JS, Devlin PM, Salgia R. Gemcitabine-induced radiation recall. International Journal of Radiation Oncology, Biology, Physics 2002;53:394-400.
7. Kachnie LA, Shaw JE, Manning MA, Lauve AD, Neifeld JP. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas. International Journal of Cancer (Radiation Oncology Investigation) 2001;96:132-139.
8. Lucas JB, Horwitz SM, Horning SJ, Sayegh A. Gemcitabine is active in relapsed Hodgkin's Disease. Journal of Clinical Oncology 1999;17:2627-2628.
9. Santoro A, Bredenfeld H, Devizzi L, Tesch H, Bonfante V, Vivani S, Fiedler F, Parra HS, Benoehr C, Pacini M, et al. Gemcitabine in the treatment of refractory Hodgkin's Disease: results of a multicenter phase II study. Journal of Clinical Oncology 2000;18:2615-2619.
10. Zinzani PL, Bendandi M, Stefoni V, Albertini P, Gherlinzoni F, Tani M, Piccaluga PP, Tura S. Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients. Haematologica 2000;85:926-929.
11. Baetz T, Belch A, Couban S, Imrie K, Yau J, Myers R, Ding K, Paul N, Shepherd L, Iglesias J, et al. Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. Annals of Oncology 2003; 14:1762-1767.
12. Chau I, Harries M, Cunningham D, Hill M, Ross PJ, Archer CD, Norman AR, Wootherspoon A, Koh DM, Gill K, et al. Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma. British Journal of Haematology 2003;120:970-977.
13. Myers BH, Spodick DH. Constrictive pericarditis: clinical and pathophysiologic characteristics. American Heart Journal 1999;138:219-232.
14. D'Cruz I, Rehman AU, Hancock HI. Quantitative echocardiographic assessment in pericardial disease. Echocardiography 1997;14:207-214.
15. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine 2003;49:684-90.
16. Oh JK, Seward JB, Tajik AJ. The Echo Manual (2nd ed.). Philadelphia, PA: Lippincott-Raven; 1999. pp 181-194.
17. Stewart JR, Cohn KE, Fajardo LF, Hancock EW, Kaplan HS. Radiation induced heart disease: a study of twenty-five patients. Radiology 1967;89:302-310.
18. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Critical Reviews in Oncology/Hematology 2003;45:55-75.
19. Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease. Cancer 1976;35:2813-2815.